Patrick Daly

Patrick Daly is a contributing writer for Cancer Nursing Today. He is an assistant editor for DocWire News with several years of experience in producing multimedia content for B2B and B2C audiences in the financial and health care industries.

Articles by Patrick Daly

Patrick DalyGVHD | December 22, 2022
Different radiotherapy doses in allogeneic HCT conditioning had no apparent impact on the rate of acute GVHD.
Read More
Patrick DalyGVHD | December 22, 2022
Authors observed that ocular graft-versus-host disease usually developed after a history of systemic disease.
Patrick DalyGVHD | December 22, 2022
A study found fecal microbiome dysbiosis accompanied the onset of gastrointestinal graft-versus-host disease.
Patrick DalyGVHD | December 22, 2022
BCG vaccination at birth was associated with increased risk of acute GVHD after HCT in pediatric patients.
Patrick DalyGVHD | December 20, 2022
Vitamin D Deficiency before HSCT was associated with increased rate of aGVHD in patients with thalassemia major.
Patrick DalyGVHD | December 20, 2022
Higher tacrolimus pharmacokinetic variability had a greater risk of aGVHD that rose alongside concentration variability.
Patrick DalyGVHD | December 20, 2022
defibrotide added to standard-of-care graft-versus-host disease prophylaxis appeared to improve the rate of acute GVHD.
Patrick DalyGVHD | December 20, 2022
FEV1/FVC and PEF/pred could identify patients with higher risk for pulmonary chronic graft-versus-host disease before HSCT.
Patrick DalyGVHD | December 7, 2022
Real-world data showed that ruxolitinib was effective in a population of heavily pretreated patients with cGVHD.
Patrick DalyGVHD | December 7, 2022
Vedolizumab was safe and effective for GI aGVHD treatment, although its efficacy as GVHD prophylaxis was unclear.